finasteride and Obesity

finasteride has been researched along with Obesity in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	2 (25.00)	2.80

Authors

Authors	Studies
Chau, CH; Figg, WD; Goodman, PJ; Neuhouser, ML; Pollak, MN; Price, DK; Thompson, IM; Till, C	1
Brady, PH; Gin, GT; Rosenblum, E; Wilkinson, LD	1
Guay, AT; Traish, AM; Zitzmann, M	1
Dunn, BK; Greenwald, P; Umar, A	1
Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM	1
Albanes, D; Chi, C; Gong, Z; Goodman, PJ; Hsing, AW; Kristal, AR; Lippman, SM; Neuhouser, ML; Platz, EA; Pollak, MN; Thompson, IM	1
Farré, M; Hernández-López, C; Peiró, AM	1
Fernández Navarro, F; Jerez Basurco, B; Martín Alvarez, M; Mora Navarro, G	1

Reviews

2 review(s) available for finasteride and Obesity

Article	Year
5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis. Hormone molecular biology and clinical investigation, 2014, Volume: 20, Issue:3 Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Diabetes Mellitus; Dutasteride; Finasteride; Glucocorticoids; Humans; Insulin Resistance; Metabolic Syndrome; Mineralocorticoids; Obesity; Vascular Diseases	2014
Future directions in cancer prevention. Nature reviews. Cancer, 2012, Volume: 12, Issue:12 Topics: Aromatase Inhibitors; Azasteroids; Breast Neoplasms; Cancer Vaccines; Diet; Dutasteride; Female; Finasteride; Humans; Immunotherapy; Life Style; Male; Motor Activity; Neoplasms; Nicotiana; Obesity; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Vaccines	2012

Article

Year

5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis.

Hormone molecular biology and clinical investigation, 2014, Volume: 20, Issue:3

Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Diabetes Mellitus; Dutasteride; Finasteride; Glucocorticoids; Humans; Insulin Resistance; Metabolic Syndrome; Mineralocorticoids; Obesity; Vascular Diseases

2014

Future directions in cancer prevention.

Nature reviews. Cancer, 2012, Volume: 12, Issue:12

Topics: Aromatase Inhibitors; Azasteroids; Breast Neoplasms; Cancer Vaccines; Diet; Dutasteride; Female; Finasteride; Humans; Immunotherapy; Life Style; Male; Motor Activity; Neoplasms; Nicotiana; Obesity; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Vaccines

2012

Trials

2 trial(s) available for finasteride and Obesity

Article	Year
Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial. Endocrine-related cancer, 2022, 01-20, Volume: 29, Issue:2 Topics: Biomarkers; Case-Control Studies; Finasteride; Humans; Male; Obesity; Prostatic Neoplasms; Risk Factors	2022
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:10 Topics: Adenocarcinoma; Age Factors; Aged; Body Mass Index; Diabetes Mellitus; Enzyme Inhibitors; Finasteride; Humans; Logistic Models; Male; Middle Aged; Neoplasm Staging; Obesity; Prostatic Neoplasms; Research Design; Risk Factors; Waist-Hip Ratio	2006

Article

Year

Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial.

Endocrine-related cancer, 2022, 01-20, Volume: 29, Issue:2

Topics: Biomarkers; Case-Control Studies; Finasteride; Humans; Male; Obesity; Prostatic Neoplasms; Risk Factors

2022

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:10

Topics: Adenocarcinoma; Age Factors; Aged; Body Mass Index; Diabetes Mellitus; Enzyme Inhibitors; Finasteride; Humans; Logistic Models; Male; Middle Aged; Neoplasm Staging; Obesity; Prostatic Neoplasms; Research Design; Risk Factors; Waist-Hip Ratio

2006

Other Studies

4 other study(ies) available for finasteride and Obesity

Article	Year
Female Pelvic Conditions: Polycystic Ovary Syndrome. FP essentials, 2022, Volume: 515 Topics: Acne Vulgaris; Anovulation; Female; Finasteride; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Infertility; Letrozole; Male; Obesity; Polycystic Ovary Syndrome; Spironolactone; Weight Loss	2022
The treatment of polycystic ovary syndrome. Minerva ginecologica, 2004, Volume: 56, Issue:1 Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss	2004
[Medications of wellbeing]. Atencion primaria, 2000, Sep-15, Volume: 26, Issue:4 Topics: Aged; Alopecia; Anti-Obesity Agents; Drug Prescriptions; Drug Therapy; Enzyme Inhibitors; Erectile Dysfunction; Female; Finasteride; Humans; Lactones; Male; Middle Aged; Nonprescription Drugs; Obesity; Orlistat; Phosphodiesterase Inhibitors; Piperazines; Psychotropic Drugs; Purines; Sildenafil Citrate; Sulfones	2000
[Wellbeing or happiness medications?]. Atencion primaria, 2001, Jun-30, Volume: 28, Issue:2 Topics: Alopecia; Anti-Obesity Agents; Enzyme Inhibitors; Erectile Dysfunction; Family Practice; Finasteride; Humans; Lactones; Male; Obesity; Orlistat; Piperazines; Purines; Sildenafil Citrate; Sulfones	2001